A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Nature Medicine2013Vol. 19(5), pp. 619–625
Citations Over TimeTop 1% of 2013 papers
Anguraj Sadanandam, Costas A. Lyssiotis, Krisztián Homicskó, Eric A. Collisson, William J. Gibb, Stephan Wullschleger, Liliane C Gonzalez Ostos, William A Lannon, Carsten Grötzinger, Maguy Del Rio, Benoît Lhermitte, Adam B. Olshen, Bertram Wiedenmann, Lewis C. Cantley, Joe W. Gray, Douglas Hanahan
Related Papers
- → Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab(2016)44 cited
- → 89 Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma(2019)14 cited
- → Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck(2009)5 cited
- → Abstract 836: ISU104, a fully human anti-ErbB3 antibody, overcomes acquired cetuximab resistance(2018)2 cited
- Concurrent Cetuximab and Irradiation for Squamous Cell Carcinoma of the Head and Neck in Vitro(2009)